UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:HSP90B1-ACTN4 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: HSP90B1-ACTN4 | FusionPDB ID: 37815 | FusionGDB2.0 ID: 37815 | Hgene | Tgene | Gene symbol | HSP90B1 | ACTN4 | Gene ID | 7184 | 81 |
Gene name | heat shock protein 90 beta family member 1 | actinin alpha 4 | |
Synonyms | ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1 | ACTININ-4|FSGS|FSGS1 | |
Cytomap | 12q23.3 | 19q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | endoplasmin94 kDa glucose-regulated proteinendothelial cell (HBMEC) glycoproteinepididymis luminal protein 35epididymis secretory sperm binding protein Li 125mheat shock protein 90 kDa beta member 1heat shock protein 90kDa beta (Grp94), member 1hea | alpha-actinin-4focal segmental glomerulosclerosis 1non-muscle alpha-actinin 4 | |
Modification date | 20200320 | 20200327 | |
UniProtAcc | P14625 | O43707 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000299767, | ENST00000497637, ENST00000252699, ENST00000390009, ENST00000424234, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 19 X 19 X 10=3610 | 27 X 38 X 12=12312 |
# samples | 25 | 48 | |
** MAII score | log2(25/3610*10)=-3.85199883711245 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(48/12312*10)=-4.68088692071969 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: HSP90B1 [Title/Abstract] AND ACTN4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | HSP90B1(104331584)-ACTN4(39219913), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | HSP90B1-ACTN4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HSP90B1-ACTN4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HSP90B1-ACTN4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. HSP90B1-ACTN4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | HSP90B1 | GO:0001666 | response to hypoxia | 15620698 |
Hgene | HSP90B1 | GO:0031247 | actin rod assembly | 19000834 |
Hgene | HSP90B1 | GO:0043666 | regulation of phosphoprotein phosphatase activity | 19000834 |
Hgene | HSP90B1 | GO:0071318 | cellular response to ATP | 19000834 |
Tgene | ACTN4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 25411248 |
Tgene | ACTN4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 22351778 |
Tgene | ACTN4 | GO:0048384 | retinoic acid receptor signaling pathway | 22351778 |
Tgene | ACTN4 | GO:0051272 | positive regulation of cellular component movement | 9508771 |
Fusion gene breakpoints across HSP90B1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ACTN4 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-HU-A4H2 | HSP90B1 | chr12 | 104331584 | + | ACTN4 | chr19 | 39219913 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000299767 | HSP90B1 | chr12 | 104331584 | + | ENST00000252699 | ACTN4 | chr19 | 39219913 | + | 3347 | 1037 | 182 | 1195 | 337 |
ENST00000299767 | HSP90B1 | chr12 | 104331584 | + | ENST00000424234 | ACTN4 | chr19 | 39219913 | + | 1196 | 1037 | 182 | 1195 | 338 |
ENST00000299767 | HSP90B1 | chr12 | 104331584 | + | ENST00000390009 | ACTN4 | chr19 | 39219913 | + | 1211 | 1037 | 182 | 1195 | 337 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000299767 | ENST00000252699 | HSP90B1 | chr12 | 104331584 | + | ACTN4 | chr19 | 39219913 | + | 0.000689608 | 0.9993104 |
ENST00000299767 | ENST00000424234 | HSP90B1 | chr12 | 104331584 | + | ACTN4 | chr19 | 39219913 | + | 0.000457901 | 0.9995421 |
ENST00000299767 | ENST00000390009 | HSP90B1 | chr12 | 104331584 | + | ACTN4 | chr19 | 39219913 | + | 0.000502168 | 0.9994978 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >37815_37815_1_HSP90B1-ACTN4_HSP90B1_chr12_104331584_ENST00000299767_ACTN4_chr19_39219913_ENST00000252699_length(amino acids)=337AA_BP=285 MRALWVLGLCCVLLTFGSVRADDEVDVDGTVEEDLGKSREGSRTDDEVVQREEEAIQLDGLNASQIRELREKSEKFAFQAEVNRMMKLII NSLYKNKEIFLRELISNASDALDKIRLISLTDENALSGNEELTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTE AQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNTLGRGTTITLVLKEEASDYLELDTIKNLVKK -------------------------------------------------------------- >37815_37815_2_HSP90B1-ACTN4_HSP90B1_chr12_104331584_ENST00000299767_ACTN4_chr19_39219913_ENST00000390009_length(amino acids)=337AA_BP=285 MRALWVLGLCCVLLTFGSVRADDEVDVDGTVEEDLGKSREGSRTDDEVVQREEEAIQLDGLNASQIRELREKSEKFAFQAEVNRMMKLII NSLYKNKEIFLRELISNASDALDKIRLISLTDENALSGNEELTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTE AQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNTLGRGTTITLVLKEEASDYLELDTIKNLVKK -------------------------------------------------------------- >37815_37815_3_HSP90B1-ACTN4_HSP90B1_chr12_104331584_ENST00000299767_ACTN4_chr19_39219913_ENST00000424234_length(amino acids)=338AA_BP=285 MRALWVLGLCCVLLTFGSVRADDEVDVDGTVEEDLGKSREGSRTDDEVVQREEEAIQLDGLNASQIRELREKSEKFAFQAEVNRMMKLII NSLYKNKEIFLRELISNASDALDKIRLISLTDENALSGNEELTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTE AQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNTLGRGTTITLVLKEEASDYLELDTIKNLVKK -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:104331584/chr19:39219913) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
HSP90B1 | ACTN4 |
FUNCTION: Molecular chaperone that functions in the processing and transport of secreted proteins (By similarity). When associated with CNPY3, required for proper folding of Toll-like receptors (By similarity). Functions in endoplasmic reticulum associated degradation (ERAD) (PubMed:18264092). Has ATPase activity (By similarity). May participate in the unfolding of cytosolic leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1 to facilitate their translocation into the ERGIC (endoplasmic reticulum-Golgi intermediate compartment) and secretion; the translocation process is mediated by the cargo receptor TMED10 (PubMed:32272059). {ECO:0000250|UniProtKB:P08113, ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:32272059}. | FUNCTION: F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein (Probable). Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation (PubMed:15772161). Involved in tight junction assembly in epithelial cells probably through interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and recruits it to the tight junctions (By similarity). May also function as a transcriptional coactivator, stimulating transcription mediated by the nuclear hormone receptors PPARG and RARA (PubMed:22351778). {ECO:0000250|UniProtKB:P57780, ECO:0000269|PubMed:15772161, ECO:0000269|PubMed:22351778, ECO:0000305|PubMed:9508771}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 778_789 | 640.0 | 693.0 | Calcium binding | 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 819_830 | 640.0 | 693.0 | Calcium binding | 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 765_800 | 640.0 | 693.0 | Domain | EF-hand 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 806_841 | 640.0 | 693.0 | Domain | EF-hand 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 649_752 | 640.0 | 693.0 | Repeat | Spectrin 4 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HSP90B1 | chr12:104331584 | chr19:39219913 | ENST00000299767 | + | 6 | 18 | 800_803 | 285.0 | 804.0 | Motif | Note=Prevents secretion from ER |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 778_789 | 859.0 | 912.0 | Calcium binding | 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 819_830 | 859.0 | 912.0 | Calcium binding | 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 19_26 | 859.0 | 912.0 | Compositional bias | Poly-Gly | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 19_26 | 640.0 | 693.0 | Compositional bias | Poly-Gly | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 163_269 | 859.0 | 912.0 | Domain | Calponin-homology (CH) 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 50_154 | 859.0 | 912.0 | Domain | Calponin-homology (CH) 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 765_800 | 859.0 | 912.0 | Domain | EF-hand 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 806_841 | 859.0 | 912.0 | Domain | EF-hand 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 163_269 | 640.0 | 693.0 | Domain | Calponin-homology (CH) 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 50_154 | 640.0 | 693.0 | Domain | Calponin-homology (CH) 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 84_88 | 859.0 | 912.0 | Motif | LXXLL motif | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 84_88 | 640.0 | 693.0 | Motif | LXXLL motif | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 177_192 | 859.0 | 912.0 | Region | Polyphosphoinositide (PIP2)-binding | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 1_269 | 859.0 | 912.0 | Region | Note=Actin-binding | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 177_192 | 640.0 | 693.0 | Region | Polyphosphoinositide (PIP2)-binding | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 1_269 | 640.0 | 693.0 | Region | Note=Actin-binding | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 293_403 | 859.0 | 912.0 | Repeat | Spectrin 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 413_518 | 859.0 | 912.0 | Repeat | Spectrin 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 528_639 | 859.0 | 912.0 | Repeat | Spectrin 3 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 649_752 | 859.0 | 912.0 | Repeat | Spectrin 4 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 293_403 | 640.0 | 693.0 | Repeat | Spectrin 1 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 413_518 | 640.0 | 693.0 | Repeat | Spectrin 2 | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 528_639 | 640.0 | 693.0 | Repeat | Spectrin 3 |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
ACTN4 | MYOZ2, MYOZ1, PDLIM1, USP6NL, P2rx7, SLC9A3R2, COL17A1, TRIM3, MAGI1, GSN, Lrrc7, CAMK2A, CAMK2B, INO80, UBTF, STAT1, HDAC7, MEF2A, UCHL5, TJP1, ATXN7, HDAC5, VDR, ESR1, PSMA3, ELAVL1, SIRT7, SLC2A4, ISG15, COIL, SACS, HGS, UBASH3B, SHC1, NOS3, ACTN2, ACTN1, FMNL1, TRAF3IP1, FN1, VCAM1, Fcho2, CDH1, ITGA4, SVIL, CD81, IGSF8, ICAM1, TXN, RPS27, POT1, KPNA2, MAPK7, CDKN2A, VCP, SF3A3, GNB2, HUWE1, ACTN3, BMP7, ALK, CUL7, OBSL1, CCDC8, EGFR, LUZP4, RARA, HSPB1, AHNAK, ALDOA, ALDOC, IDH3A, MYH15, MYH2, MYH7B, NCAPG2, PSMA6, PSMB5, PUS7, TPM2, TSG101, CKB, CYC1, ECSIT, MCFD2, PSMB8, TPM1, TPM3, TPM4, NTRK1, CAPZA2, DBN1, FLNA, MYH9, MYO1C, PPP1CB, IQGAP1, PDLIM7, SYNPO, MAPRE1, SIN3B, MYEF2, LIMA1, ANLN, MYO5C, MYO19, MYO18A, Actb, Flot2, Myh9, Myo1c, Tpm1, Coro1c, Tmod3, Lima1, Ncbp2, Calml3, Myh10, Flnb, CTNNB1, MCM2, NFYA, CDC73, LCMT2, MEOX2, SORBS2, DDIAS, SSH1, act1, SLC9A1, NCL, DLD, DNM1L, PDHA1, SOD1, TRIM25, TES, CFTR, PPM1D, HDAC4, UBE2M, RAD18, PRPF8, TNIP2, RNF4, TRIM23, AGR2, ACTA1, MYC, CDK9, KIAA1429, ATG16L1, ACTC1, USP14, HDAC2, GBF1, AGRN, DYNC1LI1, BMH1, BMH2, ATXN3, BRF1, CYB5B, GBAS, HADHB, SYNJ2BP, VDAC3, RELA, PRMT5, MDP1, GRIN1, RGS9, BIRC3, SOX2, LNX1, MICALL2, C14orf119, PLEKHA4, PINK1, FANCD2, SH2D3C, SRC, TTN, NEK4, CIT, CHMP4B, CHMP4C, PTGER4, ECT2, KIF14, KIF20A, PRC1, PRNP, MKI67, HNRNPH1, NMRAL1, NUPR1, TRIM21, Apc2, RBM39, LGALS9, YWHAE, EIF3F, INSIG1, INSIG2, RIN3, CANX, GGH, ERP44, ACO2, KDM4C, AHCY, SHMT2, IDH2, SMCHD1, AR, TP53, ACTB, ANKFY1, EZR, RDX, VASP, ZYX, TRIM37, HTRA4, NUDCD2, BGLT3, BTF3, SEPT9, UBR5, LHPP, TFRC, CTSB, CTSS, DPP4, ORF3a, ORF8, NRP1, TMPRSS2, TOP3B, CTSL, FURIN, IFITM1, ANPEP, BSG, IFITM3, TMPRSS11B, CLEC4D, ACE2, TMPRSS4, CLEC4E, nsp2, ORF10, FGD5, TMEM106B, PDE4B, PER2, OTUD3, SIK2, |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
HSP90B1 | |
ACTN4 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 108_126 | 859.0 | 912.0 | VCL | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 12_26 | 859.0 | 912.0 | VCL | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000252699 | 19 | 21 | 40_61 | 859.0 | 912.0 | VCL | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 108_126 | 640.0 | 693.0 | VCL | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 12_26 | 640.0 | 693.0 | VCL | |
Tgene | ACTN4 | chr12:104331584 | chr19:39219913 | ENST00000390009 | 12 | 14 | 40_61 | 640.0 | 693.0 | VCL |
Top |
Related Drugs to HSP90B1-ACTN4 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to HSP90B1-ACTN4 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ACTN4 | C4551527 | Focal segmental glomerulosclerosis 1 | 9 | GENOMICS_ENGLAND;UNIPROT |
Tgene | ACTN4 | C0007097 | Carcinoma | 1 | CTD_human |
Tgene | ACTN4 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | ACTN4 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Tgene | ACTN4 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Tgene | ACTN4 | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Tgene | ACTN4 | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Tgene | ACTN4 | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Tgene | ACTN4 | C0205699 | Carcinomatosis | 1 | CTD_human |
Tgene | ACTN4 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | ACTN4 | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
Tgene | ACTN4 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | ACTN4 | C1868672 | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1 | ORPHANET |
Tgene | ACTN4 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | ACTN4 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | ACTN4 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |